GSK aims to get triple therapy approved for asthma in USGlaxoSmithKline and development partner Innoviva have filed a dossier with the FDA, in a bid to get their Share XGSK aims to get triple therapy approved for asthma in UShttps://pharmaphorum.com/news/gsk-bids-to-become-first-asthma-triple-therapy-on-the-us-market/
GSK to file COPD combo a year earlier in USFiling for triple therapy later this year. Share XGSK to file COPD combo a year earlier in UShttps://pharmaphorum.com/news/gsk-brings-forward-filing-of-copd-drug/